A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Cuthbert O Simpkins, MD, FACS
Vivacelle Bio
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dignity Health Chandler Regional Medical Center
Chandler, Arizona, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- University Health
Kansas City, Missouri, United States
- Novant Healthcare
Winston-Salem, North Carolina, United States
- Oregon Health & Science University (ohsu)
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Aug 2024
- Primary completion
- 29 Jun 2026
- Completion
- 29 Jun 2026
- Last update posted
- 26 Oct 2026
- Registered enrollment
- 39
- Registry id
- NCT06072430
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.